WHY IT MATTERS: If Mississippi’s expanded eligibility criteria are signed into law, patients with conditions previously excluded from the state program may finally qualify for legal medical cannabis access through licensed providers. CLINICAL OVERVIEW: Mississippi continues to refine its medical cannabis program through legislative debate, with ongoing questions about which patient populations qualify for access and whether cannabis can be administered in clinical settings like hospitals. Expanding qualifying conditions is a clinically meaningful step, as many patients with legitimate therapeutic needs have historically been excluded from state programs due to overly narrow eligibility criteria.
Boulder and CBD: The Entourage Effect Explained
If you use CBD products, understanding the entourage effect helps explain why full-spectrum formulations may offer greater therapeutic benefit than isolated CBD alone. An overview of the entourage effect explains how CBD works synergistically with other cannabinoids, terpenes, and flavonoids found naturally in full-spectrum hemp products to produce enhanced therapeutic outcomes compared to isolated CBD alone. The concept is supported by preclinical and emerging clinical data showing that combinations of non-psychotropic cannabinoids such as CBG, CBN, and CBDV amplify anti-inflammatory, anxiolytic, and analgesic effects.
Four More States Advance Bills to Allow Medical Marijuana Access in Hospitals
The DOJ’s argument that even elderly medical marijuana patients could face armed federal agents exposes the absurdity of current federal cannabis law and the urgent need for reform. Marijuana Moment reports that four additional states are advancing legislation to allow medical marijuana use in hospital settings. This represents a growing trend toward integrating cannabis into clinical care where patients most need symptom reliefโincluding hospice, palliative care, and post-surgical recovery.
Study: Minor Cannabinoids CBDV and CBG Show Powerful Anti-Inflammatory Effects When Combined
If you or someone you love uses high-potency cannabis products regularly, this research suggests the mental health risks are realโespecially for younger users whose brains are still developing. A study published in the Journal of Ethnopharmacology found that 10 non-psychotropic phytocannabinoidsโparticularly CBDV and CBGโdemonstrated meaningful anti-inflammatory effects. Researchers from the University of Chemistry and Technology and the Czech Academy of Sciences found that CBDV significantly reduced IL-6 and TNF-ฮฑ production and inhibited NF-ฮบB activation.
The use of cannabis for pain management: Potential side effects on myofascial tissues of the musculoskeletal system.
Sensitivity of the Fasciae to the Endocannabinoid System: Production of Hyaluronan-Rich Vesicles and Potential Peripheral Effects of Cannabinoids in Fascial Tissue In Summary Myofascial tissue is a thin, strong, fibrous connective tissue...
The Pain-Relieving Effects of Tetrahydrocannabinol Differ Depending on Age
Age-Related Differences in ฮ9-TetrahydrocannabinolInduced Antinociception in Female and Male Rats In Summary Researchers have recently found that the antinociceptive effects of โ-9-tetrahydrocannabinol (THC) differ depending on the age of the subject. While...